Skip to main content
Log in

Approaches to Rationing Drugs in Hospitals

An Australian Perspective

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

The increasing need to consider rationing strategies within the healthcare environment is being driven by pressures such as the development of new medical technologies, the aging population, patient awareness and expectations, healthcare professionals’ appetite for new treatments, and government restrictions on healthcare costs. Solutions to these pressures will need to be sought urgently to avoid a situation in which quality of healthcare is affordable only for the wealthy. The fundamental principles of equity and fairness will need to be applied universally if the solutions are to be accepted by the community, patients and practitioners.

There are several measures that a hospital must have in place before the concept of drug rationing can be contemplated. The approach essentially involves ensuring rational drug approval processes based on critical review of the available data, coupled with ongoing education and audit. Thus, accurate information and clinical budgeting systems, processes which encourage and ensure structural and technical efficiencies within the drug use sequence and an effective Drug and Therapeutics committee are required to facilitate this approach.

To assist with its overriding goals of the quality use of medicines and optimal patient care, the Drug and Therapeutics committee needs to implement an effective formulary system, obtain detailed guidelines governing drug use within the institution, conduct an ongoing drug utilisation review programme, and provide education and training.

The move to consider allocative decision making (rationing) will become increasingly necessary as limits on structural and technical efficiency measures are reached. An institution will then need to decide whether to treat a particular group of patients, or provide a certain form of treatment. Improved methods for community consultation need to be explored and there must be a partnership between the health provider and the consumer in enunciating the existence of scarcity, determining priorities and ensuring that ethics and equity are not abandoned through this process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Callahan D. Allocating health resources. Hastings Cent Rep 1988; 18: 14–20

    PubMed  CAS  Google Scholar 

  2. Hunter DJ. Desperately seeking solutions: rationing dilemmas in health care. Aust Health Rev 1993; 16: 130–47

    PubMed  CAS  Google Scholar 

  3. Leeder SR. Cost cutting without blood spilling. Hosp Health Care Aust 1989; 20: 16, 18, 30

    Google Scholar 

  4. Klein R. Dimensions of rationing: who should do what? BMJ 1993; 307: 309–11

    Article  PubMed  CAS  Google Scholar 

  5. Larkins R. Patient care when medical resources are scarce. Aust Med 1989; 1: 377–9

    Google Scholar 

  6. Smith R. Rationing: the search for sunlight. BMJ 1991; 303: 1561–2

    Article  PubMed  CAS  Google Scholar 

  7. Bates EM, Lindner-Pelz S. The ethics of rationing health care. In: Health care issues. Sydney (NSW): Allen and Unwin, 1987: 131–42

    Google Scholar 

  8. Eddy DM. Rationing resources while improving quality. JAMA 1994; 272: 817–24

    Article  PubMed  CAS  Google Scholar 

  9. Charlesworth M. Distributing health-care resources. In: Bioethics in a liberal society. Cambridge: Cambridge University Press, 1993: 107–55

    Chapter  Google Scholar 

  10. Cohen D. Marginal analysis in practice: an alternative to needs assessment for contracting health care. BMJ 1994; 309: 781–5

    Article  PubMed  CAS  Google Scholar 

  11. Ham C. Priority setting in the NHS: reports from six districts. BMJ 1993; 307: 435–9

    Article  PubMed  CAS  Google Scholar 

  12. Kitzhaber JA. Prioritising health services in an era of limits: the Oregon experience. BMJ 1993; 307: 373–7

    Article  PubMed  CAS  Google Scholar 

  13. Bochner F, Martin ED, Burgess N, et al. Drug rationing in a teaching hospital: a method to assign priorities. BMJ 1994; 308: 901–5

    Article  PubMed  CAS  Google Scholar 

  14. Komesaroff P. Hard times for hospital administrators. Med J Aust 1994; 160: 468–71

    PubMed  CAS  Google Scholar 

  15. Leeder SR. Marginal reallocation in pursuit of more efficient health care. Med J Aust 1994; 160: 472–5

    PubMed  CAS  Google Scholar 

  16. Pearce MJ, Begg EJ. Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system. NZ Med J 1994; 107 (974): 101–4

    CAS  Google Scholar 

  17. Chadwick R. Fairness is at issue. BMJ 1994; 308: 907–8

    Article  PubMed  CAS  Google Scholar 

  18. Donaldson C. Formulate, don’t formularise. BMJ 1994; 308: 905

    Article  PubMed  CAS  Google Scholar 

  19. Petrie JC. First consider the overall process of care. BMJ 1994; 308: 906

    Article  PubMed  CAS  Google Scholar 

  20. Hochla PKO, Tuason VB. Pharmacy and Therapeutics Committee: cost-containment considerations. Arch Intern Med 1992; 152: 1773–5

    Article  PubMed  CAS  Google Scholar 

  21. Hogerzeil HV. Promoting rational prescribing: an international perspective. Br J Clin Pharmacol 1995; 39: 1–6

    Article  PubMed  CAS  Google Scholar 

  22. Hazlet TK, Teh-Wei H. Association between formulary strategies and hospital drug expenditures. Am J Hosp Pharm 1992; 49: 2207–10

    PubMed  CAS  Google Scholar 

  23. Maguire TM, Petrie G. A hitchhiker’s guide to establishing a drug utilisation evaluation program. Aust J Hosp Pharm 1995; 25: 315–24

    Google Scholar 

  24. Carpenter CE, Nash DB, Johnson NE. Evaluating the cost containment potential of clinical guidelines. Qual Rev Bull 1993: 119–23

    Google Scholar 

  25. Fins JJ. Praxis makes perfect? Hastings Cent Rep 1993; 23 (5): 16–9

    Article  PubMed  CAS  Google Scholar 

  26. Ioannides-Demos L, Eckert GM, McLean AJ. Pharmacoeconomic consequences of measurement and modification of hospital drug use. Pharmacoeconomics 1992; 2: 15–33

    Article  PubMed  CAS  Google Scholar 

  27. Misan GMH, Martin ED, Smith ER, et al. Drug utilisation review in a teaching hospital: experience with vancomycin. Eur J Clin Pharmacol 1990; 39: 457–61

    Article  PubMed  CAS  Google Scholar 

  28. Sanchez LA. Conducting pharmacoeconomic evaluations in a hospital setting. Hosp Pharm 1995; 30 (5): 415–6, 428

    Google Scholar 

  29. Ham C. Health care rationing. BMJ 1995; 310: 1483–4

    Article  PubMed  CAS  Google Scholar 

  30. Sulmasy DP. Physicians, cost control, and ethics. Ann Intern Med 1992; 116: 920–6

    PubMed  CAS  Google Scholar 

  31. Pillans PI. Control of high cost medicines. NZ Med J 1994; 107 (974): 5–6

    CAS  Google Scholar 

  32. Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. Pharmacoeconomics 1992; (1): 20–32

    Article  PubMed  CAS  Google Scholar 

  33. Eddy DM. Rationing by patient choice. JAMA 1991; 265: 105–8

    Article  PubMed  CAS  Google Scholar 

  34. Mooney G, Jan S, Seymour J. The NSW health outcomes initiative and economic analysis. Aust J Public Health 1994; 18: 244–8

    Article  PubMed  CAS  Google Scholar 

  35. Mechanic D. Dilemmas in rationing health care services: the case for implicit rationing. BMJ 1995; 310: 1655–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bochner, F., Burgess, N.G. & Martin, E.D. Approaches to Rationing Drugs in Hospitals. Pharmacoeconomics 10, 467–474 (1996). https://doi.org/10.2165/00019053-199610050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199610050-00004

Keywords

Navigation